About
Propel Bio Partners is a new private equity firm targeting high-potential business in the biosciences space. The firm was established during March 2022 by Dr. Leen Kawas and Richard Kayne. Dr. Kawas and Kayne established Propel Bio Partners with the mission to help biosciences businesses that have disruptive technologies further develop those technologies. The firm is especially interested in businesses that are ready to pursue clinical trials or regulatory approval, although promising businesses at other stages might also be considered. When Propel Bio Partners invests in a business, the equity firm will provide both capital and supportive guidance. Starting with Dr. Kawas and Kayne, the firm’s leadership team is a veritable who’s who of the biosciences field. Dr. Leen Kawas comes to the investment firm from Athira Pharma, of which she was both Co-Founder and Chief Executive Officer. At the pharmaceutical company, Dr. Kawas oversaw everything from drug discovery and clinical trials
Investment Focus
- Stages
- seed
- Location
- Los Angeles, US
Contact Information
Find more investors like Propel
Search Investors